Simard, Edgar P.
Rollins School of Public Health,
United States
2025 Rank: 319347
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 3667 out of 348741 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 319347 | 363877 |
| Total Cites | 2001 | 2065 |
| H-index | 16 | 16 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 15 | 15 |
| Total Cites to Single+First Authored Papers | 42 | 43 |
| Number of Single+First+Last Authored Papers | 16 | 16 |
| Total Cites to Single+First+Last Authored Papers | 44 | 45 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1948 | 2008 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.03 |
| Self-Citation Percentage |
3.10%
|
|
Simard, Edgar P.
Medtronic, Inc.,
United States
2024 Rank: 252889
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 2898 out of 333256 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 252889 | 291749 |
| Total Cites | 2295 | 2386 |
| H-index | 16 | 16 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 44 | 44 |
| Number of Single+First+Last Authored Papers | 17 | 17 |
| Total Cites to Single+First+Last Authored Papers | 47 | 48 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2219 | 2297 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.04 |
| Self-Citation Percentage |
3.81%
|
|
Simard, Edgar P.
Medtronic, Inc.,
United States
2023 Rank: 158986
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1920 out of 321279 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 158986 | 172909 |
| Total Cites | 2776 | 2887 |
| H-index | 18 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 84 | 86 |
| Number of Single+First+Last Authored Papers | 17 | 17 |
| Total Cites to Single+First+Last Authored Papers | 85 | 88 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2693 | 2796 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.03 |
| Self-Citation Percentage |
3.84%
|
|
Simard, Edgar P.
GlaxoSmithKline, USA,
United States
2022 Rank: 124673
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1482 out of 311132 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 124673 | 145595 |
| Total Cites | 3105 | 3221 |
| H-index | 18 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 96 | 98 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 99 | 101 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 3003 | 3110 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.04 |
| Self-Citation Percentage |
3.60%
|
|
Simard, Edgar P.
GlaxoSmithKline, USA,
United States
2021 Rank: 155231
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1604 out of 224174 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 155231 | 176893 |
| Total Cites | 5095 | 5327 |
| H-index | 18 | 18 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 138 | 139 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 140 | 141 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 4925 | 5127 |
| Ratio of Total Citations to Distinct Citing Papers | 1.03 | 1.04 |
| Self-Citation Percentage |
4.36%
|
|
Simard, Edgar P.
Rollins School of Public Health,
United States
2020 Rank: 103389
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
General & Internal Medicine
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 957 out of 106795 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103389 | 114124 |
| Total Cites | 4632 | 4974 |
| H-index | 19 | 19 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 14 | 14 |
| Total Cites to Single+First Authored Papers | 133 | 135 |
| Number of Single+First+Last Authored Papers | 15 | 15 |
| Total Cites to Single+First+Last Authored Papers | 133 | 135 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 4436 | 4693 |
| Ratio of Total Citations to Distinct Citing Papers | 1.04 | 1.06 |
| Self-Citation Percentage |
6.88%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.